Saillant Therapeutics
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Saillant Therapeutics is a biotechnology company that develops small molecule-based therapies for the treatment of heart failure, Alzheimer's disease, and viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saillant Therapeutics Comparables
Compare Saillant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GliaPharm SA | 83% | |
| Cornovus Pharmaceuticals Inc. | 74% | |
| HAYA Therapeutics | 70% |
Saillant Therapeutics Funding Rounds
Historical fundraising activity
Saillant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stichting RedMedTech Discovery Fund | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 45% MoM.
- Jan 20, 2026
Monthly visitors increased 153% MoM.
Saillant Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Saillant Therapeutics's valuation, stock price, and market status.
Is Saillant Therapeutics a public or private company?
Saillant Therapeutics is a private company.
What is the current stock price of Saillant Therapeutics?
Saillant Therapeutics is a private company with no public stock price. Caplight tracks Saillant Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Saillant Therapeutics worth (valuation)?
Valuation information for Saillant Therapeutics is not publicly available.
Can I buy Saillant Therapeutics stock?
Saillant Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Saillant Therapeutics's last funding round?
Funding round information for Saillant Therapeutics is not publicly available.
Who are the main investors in Saillant Therapeutics?
Key investors in Saillant Therapeutics include Stichting RedMedTech Discovery Fund.
Will Saillant Therapeutics IPO soon?
No public IPO plans have been announced for Saillant Therapeutics.
How can I track Saillant Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Saillant Therapeutics's secondary market activity and sign up for updates.